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Editorial on the Research Topic
Bone Marrow T Cells at the Center Stage in Immunological Memory
The notion that bone marrow (BM) T cells give a key contribution to adaptive immunity is increas-
ingly recognized (1–3). Researchers now more often include the BM when analyzing T cell responses 
in experimental mouse models (4, 5) or when providing an overview of memory T cell compart-
mentalization (6). Translation of BM T cell knowledge into medicine has begun. Promising results 
of the first clinical trial using BM T cells in the treatment of multiple myeloma (MM) were reported 
last year (7). Further applications are expected in the near future, as BM T cells have been involved 
in a variety of processes, going from normal hematopoiesis to bone resorption in patients affected 
by hyperparathyroidism (8, 9).
This research topic on BM T cells contains two sections. The first one contains original research 
contributions on BM memory CD4 and CD8 T cells in mouse models (Hojyo et al.; Geerman et al.) 
and hosts a debate on the role of BM memory T cells in systemic or localized memory (Di Rosa; 
Sercan-Alp and Radbruch; Di Rosa and Gebhardt). In the second one, emerging scenarios in 
translational medicine in different fields (e.g., hematology, oncology, transplantation immunology, 
osteoimmunology, etc.) are discussed (Wakkach et al.; Borrello and Noonan; Szyska and Na; Pacifici; 
Bonomo et al.).
MEMorY t CEllS iN tHE BM
The BM harbors a high frequency of antigen-specific memory T cells against vaccines, pathogens, and 
tumors and is considered a major site for the maintenance of memory T cells (reviewed by Di Rosa 
and Gebhardt). In addition to conventional memory T cells, another class of non-recirculating 
subsets—the so-called tissue-resident memory T cells (Trm)—has recently been identified in several 
non-lymphoid organs including skin, gut, and brain (10, 11). These cells, which can provide a first-
line defense against reinfection at barrier surfaces, are characterized by expression of CD69 as well 
as integrins such as CD103 and VLA1, which can contribute to their tissue retention (reviewed in 
Di Rosa and Gebhardt). BM has a high proportion of CD69+ memory T cells (2, 3, 12), as confirmed 
in an original report by Geerman et al. in this research topic. However, the expression of CD69 may 
not be sufficient to define these T cells as “tissue resident.” Di Rosa and Gebhardt discuss the evidence 
that BM T cells are largely circulatory, likely stopping over temporarily in BM niches where they 
receive survival signals, before re-entering the circulation.
An issue of some debate has been the extent of homeostatic proliferation of the memory T cells in 
these niches [Di Rosa; Sercan-Alp and Radbruch; (3, 13–16)]. Sercan-Alp and Radbruch have sug-
gested (3) that the level of homeostatic proliferation measured by BrdU is overestimated. However, 
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this remains a point of contention. As often found when research 
groups disagree, the experimental details may offer a solution. 
One group found, for example, that MyD88 negative mice 
did not have unexpectedly high rates of BrdU incorporation 
(Sercan-Alp and Radbruch), suggesting that the BrdU may have 
been LPS contaminated. Another found that proliferation rates 
were similar with BrdU and CFSE labels (13). As documented 
by Di  Rosa in her commentary, a variety of experimental 
approaches have provided evidence that the level of proliferation 
of memory T cells in the BM, while low, is higher than the level 
of homeostatic proliferation of T cells in spleen or LN. Thus, it is 
likely that the niches in the BM that are rich in cytokines such as 
IL-7 and IL-15, while largely providing survival signals may also 
induce a low level of proliferation, sufficient to at least partially 
support homeostasis. A recent hypothesis proposes that memory 
T cells circulating through the BM may stop to rest for a while 
in dedicated niches supporting quiescence and/or proliferate in 
distinct niches for self-renewal, before moving on (16).
In an original research article, Geerman et al. provide evidence 
that the frequency and phenotype of different subsets of memory 
T cells as well as their expression of cytokine receptors was similar 
in different bones in the steady state and after an acute systemic 
infection with lymphocytic choriomeningitis. This is reassuring 
for investigators who may wish to use different bones in their 
studies. Of note, the vertebrae, which contain the most BM cells, 
also provide the most abundant source of T cells.
In an original research contribution, Hojyo et  al. focus on 
memory CD4 T cells and show that B cell depletion increases the 
number of CD49b+Tbet+ TCR transgenic CD4 memory T cells 
in the BM. Whether B cell depletion has a direct effect on the 
CD4 T cells or affects their access to another factor which in turn 
regulates their expression of CD49+ and/or BM localization is not 
yet clear.
BM t CEllS iN traNSlatioNal 
MEdiCiNE
The activation state of freshly isolated BM T cells, e.g., result-
ing from exposure to IL-15 in the organ, together with their 
prompt response to in vitro stimulation makes these cells ideal 
candidates for adoptive transfers in conditions requiring highly 
active effectors (17–19). The article by Borrello and Noonan 
recapitulates concepts and results on the use of marrow-
infiltrating lymphocytes (MILs) against MM in humans and 
discusses the unique opportunity to exploit BM T cells in adop-
tive T-cell therapy against both hematological and solid cancers. 
Moreover, MIL transfer might ameliorate bone disease in MM 
patients, by switching BM T cells from Th17 to Th1 [Borrello 
and Noonan; (20)].
By contrast, in HSC transplantation (HSCT), donor T cell 
effector function against host BM stroma is detrimental for donor 
HSC seeding and hematopoiesis reconstitution. Starting with the 
recent recognition that BM is a major target organ in GVHD after 
allogeneic HSCT in leukemic patients (21), Szyska and Na discuss 
some possible mechanisms underlying this adverse effect, e.g., 
T-cell-derived cytolytic factors and cytokines can damage osteo-
blasts, endothelia, and surrounding cells, while replenishment of 
destroyed niches by hematopoietic cells is impaired.
Two articles link BM T cell-derived TNF-alpha and IL-17 to 
altered bone metabolism in human diseases. Pacifici discusses 
the evidence suggesting that catabolic effects of parathyroid 
hormone on bone in patients affected by hyperparathyroidism 
relies on Th17 cell-induced RANKL release by osteoblasts and 
osteocytes, with subsequent osteoclast-mediated bone resorption 
(9). Wakkach et al. give an overview of the mechanisms support-
ing bone destruction in inflammatory bowel disease and propose 
that TNF-alpha-producing Th17 cells in the BM sustain bone loss 
in patients with Crohn’s disease (22).
Bonomo et al. review the evidence that BM T cells are at the 
cross-roads between immunity, bone metabolism, and hemat-
opoiesis and propose that T cells act as messengers who “bring 
the news” from the periphery to the BM. According to this 
view, activated T cells enter the BM and modulate BM-resident 
cell function, ultimately tuning blood cell production and 
bone remodeling to the class of peripheral immune response 
(Bonomo et al.).
aUtHor CoNtriBUtioNS
TW wrote the paragraph on memory T cells in the BM; FD wrote 
the paragraph on BM T cells in Translational Medicine; FD and 
TW together wrote the remaining parts and edited the final text.
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